A combined formulation intended for studying multiple signalling components within one experimental system, BPC-157 + TB-500 + GHK-Cu + KPV blend.
| Title |
|---|
| 4 vials (15% discount) |
| 8 vials (25% discount) |
| 12 vials (35% disocunt) |
KLOW is a multi-compound research formulation commonly described as a combination of BPC-157, TB-500, GHK-Cu and KPV. These compounds are individually investigated for their involvement in tissue repair, inflammatory signaling, cellular regulation and extracellular matrix remodeling.
BPC-157 is a synthetic pentadecapeptide investigated primarily in preclinical models of tissue protection and repair. Experimental research has explored its interactions with angiogenesis, fibroblast activity and nitric oxide-associated signaling pathways.
TB-500 is associated with thymosin beta-4 research, particularly biological processes involving actin regulation, cellular migration and tissue remodeling. The specific biological activity depends on the peptide sequence used, and findings involving full-length thymosin beta-4 cannot automatically be attributed to every TB-500 preparation.
GHK-Cu is a copper-binding tripeptide complex investigated for its involvement in collagen regulation, fibroblast activity, extracellular matrix maintenance and cellular signaling.
KPV is a synthetic tripeptide derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (ฮฑ-MSH). It has been investigated in preclinical research examining inflammatory signaling, epithelial biology and immune-associated cellular responses.
KLOW 80 mg is presented as an experimental multi-compound formulation for laboratory and scientific applications. The stated quantity refers to the total compound content and should not be interpreted as a recommended human dosage.
Product: KLOW
Strength: 80 mg total
Composition: BPC-157 + TB-500 + GHK-Cu + KPV
Category: Recovery
Compound classification: Experimental multi-peptide and copper-peptide formulation
Research targets: Tissue repair-associated pathways, inflammatory signaling, cytoskeletal regulation and extracellular matrix maintenance
Research focus: Cellular repair, tissue remodeling, inflammatory regulation, fibroblast activity and epithelial biology
Intended use: Laboratory and research use only
WOLVERINE is a multi-peptide research formulation of BPC-157 and TB-500. These peptides are individually investigated for their involvement in tissue repair, cellular migration, inflammatory signaling and extracellular matrix remodeling.
Associated with Thymosin Beta-4, a naturally occurring peptide involved in tissue repair, wound healing and cellular regeneration. Research explores its role in cell migration, blood vessel formation (angiogenesis), inflammatory regulation and tissue remodeling, including recovery in muscle, tendon, skin and cardiovascular tissue.
A tripeptide corresponding to the C-terminal sequence Lys-Pro-Val associated with ฮฑ-MSH biology. Research interest centres on cellular signalling involved in inflammatory and immune-regulatory processes.
A multi-component research formulation combining peptides associated with cellular repair, extracellular-matrix signalling and tissue-remodelling research. The final page should identify every component and its exact amount rather than marketing GLOW as a single molecular entity.
A synthetic 15-amino-acid peptide extensively investigated in preclinical models involving cellular protection, vascular signalling and tissue-repair biology. Despite considerable experimental interest, human clinical evidence remains limited and no approved therapeutic formulation exists.
A synthetic peptide derived from the helix-B region of erythropoietin (EPO), investigated for tissue-protective signalling without reproducing EPOโs erythropoietic activity. Its research landscape includes inflammatory regulation, cellular protection and tissue-repair signalling pathways.